153 related articles for article (PubMed ID: 25332035)
1. Hepatocellular carcinoma in Australia's Northern Territory: high incidence and poor outcome.
Parker C; Tong SY; Dempsey K; Condon J; Sharma SK; Chen JW; Sievert W; Davis JS
Med J Aust; 2014 Oct; 201(8):470-4. PubMed ID: 25332035
[TBL] [Abstract][Full Text] [Related]
2. A "one stop liver shop" approach improves the cascade-of-care for Aboriginal and Torres Strait Islander Australians living with chronic hepatitis B in the Northern Territory of Australia: results of a novel care delivery model.
Hla TK; Bukulatjpi SM; Binks P; Gurruwiwi GG; Dhurrkay RG; Davies J
Int J Equity Health; 2020 May; 19(1):64. PubMed ID: 32381081
[TBL] [Abstract][Full Text] [Related]
3. Trends in cancer incidence and survival for Indigenous and non-Indigenous people in the Northern Territory.
Condon JR; Zhang X; Dempsey K; Garling L; Guthridge S
Med J Aust; 2016 Nov; 205(10):454-458. PubMed ID: 27852183
[TBL] [Abstract][Full Text] [Related]
4. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
5. Cancer incidence and survival for indigenous Australians in the Northern Territory.
Condon JR; Armstrong BK; Barnes T; Zhao Y
Aust N Z J Public Health; 2005 Apr; 29(2):123-8. PubMed ID: 15915615
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and survival of hepatocellular carcinoma in north-east Peninsular Malaysia.
Norsa'adah B; Nurhazalini-Zayani CG
Asian Pac J Cancer Prev; 2013; 14(11):6955-9. PubMed ID: 24377632
[TBL] [Abstract][Full Text] [Related]
7. Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.
Hong TP; Gow P; Fink M; Dev A; Roberts S; Nicoll A; Lubel J; Kronborg I; Arachchi N; Ryan M; Kemp W; Knight V; Farrugia H; Thursfield V; Desmond P; Thompson AJ; Bell S
Hepatology; 2016 Apr; 63(4):1205-12. PubMed ID: 26435297
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological trends of hepatocellular carcinoma in Austria.
Pinter M; Hucke F; Zielonke N; Trauner M; Sieghart W; Peck-Radosavljevic M
Dig Dis; 2014; 32(6):664-9. PubMed ID: 25376282
[TBL] [Abstract][Full Text] [Related]
9. Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia.
Clark PJ; Stuart KA; Leggett BA; Crawford DH; Boyd P; Fawcett J; Whiteman DC; Baade PD
Liver Int; 2015 Dec; 35(12):2584-94. PubMed ID: 25900432
[TBL] [Abstract][Full Text] [Related]
10. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study.
Jepsen P; Andersen MW; Villadsen GE; Ott P; Vilstrup H
Liver Int; 2017 Jun; 37(6):871-878. PubMed ID: 27943604
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in Australia 1982-2014: Increasing incidence and improving survival.
Wallace MC; Preen DB; Short MW; Adams LA; Jeffrey GP
Liver Int; 2019 Mar; 39(3):522-530. PubMed ID: 30230194
[TBL] [Abstract][Full Text] [Related]
12. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.
Aizawa Y; Shibamoto Y; Takagi I; Zeniya M; Toda G
Cancer; 2000 Jul; 89(1):53-9. PubMed ID: 10897000
[TBL] [Abstract][Full Text] [Related]
13. Clinical features in hepatocellular carcinoma and the impact of autopsy on diagnosis. A study of 530 cases from a low-endemicity area.
Kaczynski J; Hansson G; Wallerstedt S
Hepatogastroenterology; 2005; 52(66):1798-802. PubMed ID: 16334780
[TBL] [Abstract][Full Text] [Related]
14. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
15. Incidence and survival after acute myocardial infarction in Indigenous and non-Indigenous people in the Northern Territory, 1992-2004.
You J; Condon JR; Zhao Y; Guthridge S
Med J Aust; 2009 Mar; 190(6):298-302. PubMed ID: 19296809
[TBL] [Abstract][Full Text] [Related]
16. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
[TBL] [Abstract][Full Text] [Related]
17. Kentucky hepatoma: epidemiologic variant or same problem in a different region?
Martin RC; Loehle J; Scoggins CR; McMasters KM
Arch Surg; 2007 May; 142(5):431-6; discussion 436-7. PubMed ID: 17515484
[TBL] [Abstract][Full Text] [Related]
18. Changes in the clinical and epidemiological features of group A streptococcal bacteraemia in Australia's Northern Territory.
Gear RJ; Carter JC; Carapetis JR; Baird R; Davis JS
Trop Med Int Health; 2015 Jan; 20(1):40-7. PubMed ID: 25354844
[TBL] [Abstract][Full Text] [Related]
19. Rising incidence of hepatitis B-related hepatocellular carcinoma in South Australia: 1996-2010.
Chinnaratha MA; Graham C; Fraser RJ; Woodman RJ; Wigg AJ
Intern Med J; 2016 Aug; 46(8):902-8. PubMed ID: 27130077
[TBL] [Abstract][Full Text] [Related]
20. The natural history of chronic hepatitis B: a retrospective study.
Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
